Melbourne Haematology

Associate Professor Ashish Bajel consults at: The Royal Melbourne Hospital

Suite 11, Level 3,
Private Medical Centre
The Royal Melbourne Hospital
Royal Parade
Parkville VIC 3050
Tel: 03 9968 0011
Fax: 03 9969 0011

Essendon

SaiMed Specialist Centre
161 Keilor Rd
Essendon VIC 3040
Tel: 03 9379 4114
Tel: 03 9379 4545
Fax: 03 9379 4115

View Map of Room's Location

MBBS FRACP FRCPA

• Consultant Haematologist

Associate Professor Ashish Bajel is a Consultant Haematologist and Bone Marrow Transplant Physician at The Royal Melbourne Hospital. He graduated from University of Mumbai, India followed by specialist training in internal medicine and haematology culminating in a DM (Clinical Haematology). He subsequently became a fellow of The Royal College of Pathologists (RCPA) and Physicians (RACP) specializing in clinical and laboratory Haematology.

Assoc. Prof Bajel is actively involved in clinical research as a principal investigator and associate investigator in a wide range of clinical trials at the Royal Melbourne Hospital.

"Assoc. Prof Bajel has expertise across a range of benign and malignant haematological conditions with a special emphasis on lymphomas, myelomas, myelodysplastic and myeloproliferative disorders. He also consults on patients with clotting and bleeding disorders"

Select Publications

1. Ananda-Rajah MR, Grigg A, Downey MT, Bajel A, et al. Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia / myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period. Haematologica. 2012 Mar; 97(3):459-63.
2. Bajel A, Yin Lin M, Hill PA, Goodman D et al. IgA nephropathy associated with cutaneous T cell lymphoma. Leuk Lymphoma. 2009 Dec; 50(12):2083-5.
3. Edison ES, Bajel A, Chandy M. Iron homeostasis: new players, newer insights. Eur J Haematol. 2008 Dec; 81(6):411-24. Review
4. Bajel A, George B, Mathews V, Viswabandya A, et al. Treatment of Children with Acute Lymphoblastic Leukemia in India using a BFM Protocol. Pediatr Blood Cancer. 2008 Nov; 51(5):621-5.
5. Bajel A, George B, Mathews V, Viswabandya et al. Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol. Leukemia. 2007 Oct; 21(10):2230-5
6. Mathews V, George B, Lakshmi KM, Viswabandya A, et al. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood. 2006 Apr 1; 107(7):2627-32.

Memberships

• American Society of Haematology (ASH)
• Australasian Leukemia and Lymphoma Group (ALLG)
• Haematology Society of Australasia and New Zealand (HSANZ)